Last Updated: November 19, 2026

Details for Patent: 8,871,761

« Back to Dashboard


Which drugs does patent 8,871,761 protect, and when does it expire?

Patent 8,871,761 protects VEOZAH and is included in one NDA.

This patent has twenty-six patent family members in twenty-one countries.

Summary for Patent: 8,871,761
Title:NK-3 receptor selective antagonist compounds, pharmaceutical composition and methods for use in NK-3 receptors mediated disorders
Abstract:The present invention is directed to novel compounds of formula I and their use as therapeutic compounds.
Inventor(s):Hamid R. Hoveyda, Marie-Odile Roy, Graeme Lovat Fraser, Guillaume Dutheuil
Assignee: Ogeda SA
Application Number:US13/627,091
Patent Claim Types:
see list of patent claims
Compound;

Drugs Protected by US Patent 8,871,761

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Astellas VEOZAH fezolinetant TABLET;ORAL 216578-001 May 12, 2023 RX Yes Yes 8,871,761 ⤷  Start Trial Y ⤷  Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

International Family Members for US Patent 8,871,761

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Australia 2011234398 ⤷  Start Trial
Brazil 112012025101 ⤷  Start Trial
Canada 2793313 ⤷  Start Trial
China 102906093 ⤷  Start Trial
Cyprus 1120307 ⤷  Start Trial
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.